CJC-1295 with DAC (Drug Affinity Complex) from Hilma Biocare is a long-acting synthetic peptide designed to stimulate the secretion of Growth Hormone. The addition of the DAC complex allows the peptide to bond with blood albumin, significantly extending its lifespan in the body compared to standard versions.

Product Overview

• Type: Growth Hormone Releasing Hormone (GHRH) agonist.
• Primary Function: It signals the pituitary gland to release Growth Hormone (GH), which can aid in muscle recovery, fat loss, and improved sleep quality.
• Half-Life: Approximately 6 to 8 days, meaning it provides a steady elevation of GH levels rather than a short pulse.

Standard Dosage and Cycle

In most research contexts, the following parameters are used:

• Weekly Dose: 2mg is the most common total weekly amount.
• Frequency: Usually split into two injections of 1mg (e.g., Monday and Thursday) to maintain stable blood levels.
• Cycle Length: Typically used for 12 to 24 weeks. Longer cycles are often preferred because the effects on body composition are gradual.

Preparation and Handling

1. Reconstitution: You must mix the dry powder with Bacteriostatic Water. Gently swirl the vial; do not shake it vigorously, as peptides are fragile.
2. Administration: It is administered via subcutaneous injection, usually in the fatty tissue around the stomach.
3. Storage:
• Keep the unmixed vials in a cool, dark place.
• Once mixed, the solution must be refrigerated at 2°C to 8°C and used within about 3 weeks.

Common Side Effects

• The "Flush": A temporary feeling of warmth or a red face immediately after injecting.
• Increased Hunger: Though less pronounced than with some other peptides, an increase in appetite is common.
• Water Retention: Some users experience mild swelling in the joints or extremities.
• Injection Site Irritation: Redness or itching at the spot of the needle entry.